Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (101-110 of 364) with videos related to

Pageof 37
Sort By:
Eclinicalmedicine|April 15, 2024
Effectiveness of the Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation in EnglandFreja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, et al.
The Journal of Infection|December 29, 2024
COVID-19 reinfection in pregnancy: Assessment of severity and pregnancy outcomes in EnglandAnna A Mensah, Julia Stowe, Kevin Brown, et al.
BMJ Open|September 26, 2024
Identifying markers of health-seeking behaviour and healthcare access in UK electronic health recordsSophie Graham, Jemma L Walker, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2023
Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 YearsJamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2016
Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following IntroductionGayatri Amirthalingam, Helen Campbell, Sonia Ribeiro, et al.
Archives of Disease in Childhood|July 8, 2022
PEPtalk 3: oral aciclovir is equivalent to varicella zoster immunoglobulin as postexposure prophylaxis against chickenpox in children with cancer - results of a multicentre UK evaluationClaire Cuerden, Charlotte Gower, Kevin Brown, et al.
The Journal of Infection|July 12, 2024
The impact of COVID-19 vaccine spring boosters on COVID-19 hospital admissions in England 2022/23Nick Andrews, Itunu Osuntoki, Julia Stowe, et al.
The Lancet. Public Health|December 26, 2017
Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based studyGayatri Amirthalingam, Nick Andrews, Philip Keel, et al.
BMJ Open|February 1, 2020
Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysisDaniel J Grint, Helen I McDonald, Jemma L Walker, et al.
Influenza and Other Respiratory Viruses|May 21, 2009
Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strainsKatja Höschler, Robin Gopal, Nick Andrews, et al.
Pageof 37

Showing results (101-110 of 364) with videos related to

Sort By:
Pageof 37
Eclinicalmedicine|April 15, 2024
Effectiveness of the Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation in EnglandFreja Cordelia Møller Kirsebom, Nick Andrews, Julia Stowe, et al.
The Journal of Infection|December 29, 2024
COVID-19 reinfection in pregnancy: Assessment of severity and pregnancy outcomes in EnglandAnna A Mensah, Julia Stowe, Kevin Brown, et al.
BMJ Open|September 26, 2024
Identifying markers of health-seeking behaviour and healthcare access in UK electronic health recordsSophie Graham, Jemma L Walker, Nick Andrews, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2023
Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 YearsJamie Lopez Bernal, Nick Andrews, Charlotte Gower, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2016
Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following IntroductionGayatri Amirthalingam, Helen Campbell, Sonia Ribeiro, et al.
Archives of Disease in Childhood|July 8, 2022
PEPtalk 3: oral aciclovir is equivalent to varicella zoster immunoglobulin as postexposure prophylaxis against chickenpox in children with cancer - results of a multicentre UK evaluationClaire Cuerden, Charlotte Gower, Kevin Brown, et al.
The Journal of Infection|July 12, 2024
The impact of COVID-19 vaccine spring boosters on COVID-19 hospital admissions in England 2022/23Nick Andrews, Itunu Osuntoki, Julia Stowe, et al.
The Lancet. Public Health|December 26, 2017
Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based studyGayatri Amirthalingam, Nick Andrews, Philip Keel, et al.
BMJ Open|February 1, 2020
Safety of inadvertent administration of live zoster vaccine to immunosuppressed individuals in a UK-based observational cohort analysisDaniel J Grint, Helen I McDonald, Jemma L Walker, et al.
Influenza and Other Respiratory Viruses|May 21, 2009
Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strainsKatja Höschler, Robin Gopal, Nick Andrews, et al.
Pageof 37